Orgenesis Inc. (NasdaqCM:ORGS) entered into a binding Term Sheet agreement to acquire Octomera LLC from MM OS Holdings, L.P. on January 15, 2024. The transaction is subject to approval by The Board of Directors of Orgenesis.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.5149 USD | +5.95% | +7.27% | +2.84% |
May. 20 | Orgenesis Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 16 | North American Morning Briefing : Powell Comments, -2- | DJ |
1st Jan change | Capi. | |
---|---|---|
+2.84% | 16.57M | |
-7.16% | 177B | |
-4.86% | 65.54B | |
-4.28% | 47.09B | |
+10.32% | 43.43B | |
+8.14% | 41.77B | |
+15.76% | 29.55B | |
+15.53% | 24.83B | |
-5.88% | 23.97B | |
-5.38% | 23.54B |
- Stock Market
- Equities
- ORGS Stock
- News Orgenesis Inc.
- Orgenesis Inc. entered into a binding Term Sheet agreement to acquire Octomera LLC from MM OS Holdings, L.P.